These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9657629)

  • 61. Effects of lipopolysaccharide on the blood-brain barrier permeability in prolonged nitric oxide blockade-induced hypertensive rats.
    Ahishali B; Kaya M; Kalayci R; Uzun H; Bilgic B; Arican N; Elmas I; Aydin S; Kucuk M
    Int J Neurosci; 2005 Feb; 115(2):151-68. PubMed ID: 15763998
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive rat.
    Khattab MM; Mostafa A; Al-Shabanah O
    Kidney Blood Press Res; 2005; 28(4):243-50. PubMed ID: 16220007
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
    Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats.
    Hropot M; Langer KH; Wiemer G; Grötsch H; Linz W
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):312-7. PubMed ID: 12644905
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Spironolactone differently influences remodeling of the left ventricle and aorta in L-NAME-induced hypertension.
    Simko F; Matúsková J; Lupták I; Pincíková T; Krajcírovicová K; Stvrtina S; Pomsár J; Pelouch V; Paulis L; Pechánová O
    Physiol Res; 2007; 56 Suppl 2():S25-S32. PubMed ID: 17824810
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of imidapril on left ventricular mass in chronic hemodialysis patients.
    Matsumoto N; Ishimitsu T; Okamura A; Seta H; Takahashi M; Matsuoka H
    Hypertens Res; 2006 Apr; 29(4):253-60. PubMed ID: 16778332
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of chronic increased salt intake on nitric oxide synthesis inhibition-induced hypertension.
    Fernández-Rivas A; García-Estañ J; Vargas F
    J Hypertens; 1995 Jan; 13(1):123-8. PubMed ID: 7759842
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effect of enalapril and verapamil on the left ventricular hypertrophy and the left ventricular cardiomyocyte numerical density in rats submitted to nitric oxide inhibition.
    Pereira LM; Mandarim-De-Lacerda CA
    Int J Exp Pathol; 2001 Apr; 82(2):115-22. PubMed ID: 11454102
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of kinins and nitric oxide in the antihypertrophic effect of ramipril.
    Rhaleb NE; Yang XP; Scicli AG; Carretero OA
    Hypertension; 1994 Jun; 23(6 Pt 2):865-8. PubMed ID: 7515854
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Asiatic acid alleviates cardiovascular remodelling in rats with L-NAME-induced hypertension.
    Bunbupha S; Prachaney P; Kukongviriyapan U; Kukongviriyapan V; Welbat JU; Pakdeechote P
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1189-97. PubMed ID: 26234646
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.
    Tsukamoto O; Minamino T; Sanada S; Okada K; Hirata A; Fujita M; Shintani Y; Yulin L; Asano Y; Takashima S; Yamasaki S; Tomoike H; Hori M; Kitakaze M
    Cardiovasc Drugs Ther; 2006 Apr; 20(2):93-102. PubMed ID: 16761190
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats.
    Pechanova O; Matuskova J; Capikova D; Jendekova L; Paulis L; Simko F
    Kidney Int; 2006 Jul; 70(1):170-6. PubMed ID: 16710350
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
    Uhlenius N; Vuolteenaho O; Tikkanen I
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of a novel ACE inhibitor, 3-(3-thienyl)-l-alanyl-ornithyl-proline, on endothelial vasodilation and hepatotoxicity in l-NAME-induced hypertensive rats.
    Seth MK; Hussain ME; Pasha S; Fahim M
    Drug Des Devel Ther; 2016; 10():1533-42. PubMed ID: 27143859
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diverse effects of long-term treatment with imidapril and irbesartan on cell growth signal, apoptosis and collagen type I expression in the left ventricle of spontaneously hypertensive rats.
    Wang JM; Wang Y; Zhu ZS; Zhang MC; Zou Y; Li JJ; Li MJ; Jiang XJ; Li XY
    Life Sci; 2004 Jun; 75(4):407-20. PubMed ID: 15147828
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nitric oxide release from kidneys of hypertensive rats treated with imidapril.
    Hirata Y; Hayakawa H; Kakoki M; Tojo A; Suzuki E; Kimura K; Goto A; Kikuchi K; Nagano T; Hirobe M; Omata M
    Hypertension; 1996 Mar; 27(3 Pt 2):672-8. PubMed ID: 8613223
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function.
    Higashi Y; Sasaki S; Nakagawa K; Matsuura H; Kajiyama G; Oshima T
    J Am Coll Cardiol; 2001 Mar; 37(3):863-70. PubMed ID: 11693763
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition.
    Sainz J; Wangensteen R; Rodríguez Gómez I; Moreno JM; Chamorro V; Osuna A; Bueno P; Vargas F
    Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of omapatrilat on blood pressure and renal injury in L-NAME and L-NAME plus DOCA-treated rats.
    Rodriguez-Gomez I; Wangensteen R; Atucha NM; O'Valle F; Del Moral RG; Garcia-Estañ J; Vargas F; Osuna A
    Am J Hypertens; 2003 Jan; 16(1):33-8. PubMed ID: 12517680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.